Corbus Pharmaceuticals Holdings, Inc. Annual Depreciation in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly/annual Depreciation history and growth rate from 2014 to 2023.
  • Corbus Pharmaceuticals Holdings, Inc. Depreciation for the quarter ending September 30, 2024 was $200K, unchanged year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. Depreciation for the twelve months ending September 30, 2024 was $611K, a 20.3% decline year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. annual Depreciation for 2023 was $641K, a 16% decline from 2022.
  • Corbus Pharmaceuticals Holdings, Inc. annual Depreciation for 2022 was $763K, a 23.7% decline from 2021.
  • Corbus Pharmaceuticals Holdings, Inc. annual Depreciation for 2021 was $1M, a 11% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $641K -$122K -16% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 $763K -$237K -23.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $1M -$124K -11% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 $1.12M +$385K +52.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-08
2019 $739K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-15
2016 $88K +$44K +100% Jan 1, 2016 Dec 31, 2016 10-K 2017-03-08
2015 $44K +$33.6K +323% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-08
2014 $10.4K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.